Welcome back to this month's edition of The Boesen & Snow Brief. This month, we're covering what matters in the first week of a PBM audit, interviewing our M&A attorney on what buyers and sellers should know before signing a letter of intent, and looking at how regulators read healthcare marketing pages. 

Got a PBM Audit Notice? Here's What Actually Matters in Week One

An audit notice reads like an administrative task with a due date, and treating it that way is one of the most common ways a manageable audit turns expensive. Mark Boesen, PharmD., JD, and Mark Ziegler, PharmD., MBA, cover what to do immediately, what most pharmacies never think to ask for, and why the provider manual is the real rulebook.

Additional Articles:

We sat down with Franci Fealk, J.D., who has represented buyers and sellers for nearly a decade, to talk through how deals get structured, why the letter of intent matters more than most people think, and what protects each side when a transaction gets complicated.

Read More

Your marketing might be drawing attention from regulators and brand manufacturers. Megan Davis, J.D., covers the language and imagery that creates risk, the pages most reviews skip, and what's at stake once a warning letter arrives.

Read More

The BSL newsletter is provided for general informational purposes, does not constitute legal advice, and does not create an attorney-client relationship. The regulatory status of the matters discussed is current as of publication and is subject to change. This may be considered legal services marketing. Our ability to represent clients in a particular matter depends on that state's licensure and admission requirements, which may require pro hac vice admission or association with local counsel.